Journal
EFSA JOURNAL
Volume 20, Issue 10, Pages -Publisher
WILEY
DOI: 10.2903/j.efsa.2022.7449
Keywords
novel food; beta-hydroxybutyrate; calcium; magnesium; sodium; chemical synthesis; food supplements
Categories
Ask authors/readers for more resources
The EFSA Panel evaluated the safety of beta-hydroxybutyrate (BHB) salts as a novel food, finding the data provided by the applicant unsatisfactory and unable to establish a safe intake level. The safety of the NF has not been established.
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on beta-hydroxybutyrate (BHB) salts as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of sodium, magnesium and calcium BHB salts, and is proposed to be used by adults as a food ingredient in a number of food categories and as food supplement. The data provided by the applicant about the identity, the production process and the compositional data of the NF over the course of the risk assessment period were overall considered unsatisfactory. The Panel noted inconsistencies in the reporting of the test item used in the subchronic toxicity study and human studies provided by the applicant. Owing to these deficiencies, the Panel cannot establish a safe intake level of the NF. The Panel concludes that the safety of the NF has not been established. (C) 2022 Wiley-VCH Verlag GmbH & Co. KgaA on behalf of the European Food Safety Authority.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available